Multivariable Cox regression models estimating time to event for four outcome categories (MET/SU monotherapy). The figure shows the results of the multivariable Cox regression analysis with regard to independent factors influencing time until an event (all-cause event as well as mortality, MACE and T2DM-related hospitalizations in separate models) in the T2DM-incident sample that received either SU or MET monotherapy. (TIF 164 kb
The selection process of study sample to determine optimal cut-points for prediction of type 2 diabe...
AHAs included in baseline regimen and with continued use in follow-up in patients with baseline and ...
Figure A2. Subgroup of OS2006 historical data (SARC-OS data). Observed Kaplan-Meier and parametric e...
Kaplan-Meier (KM) curves for all-cause death rates, macrovascular event rates and T2DM-related hospi...
Kaplan-Meier (KM) curves for crude all-cause death rates, macrovascular event rates and T2DM-related...
Distribution of propensity scores as calculated by logistic regression for MET/SU monotherapy users....
Kaplan-Meier (KM) curves for crude all-cause death rates, macrovascular event rates and T2DM-related...
Flow diagram of participants. Chart showing the number of participants who were randomly assigned, t...
Additional file 1: Table S1. Descriptive statistics for each drug and dose amount at index date in e...
A table showing adjusted hazard ratios based on the Cox proportional hazards model of 2-year mortali...
Additional file 5: Figure S3. Risk for cardiovascular and kidney outcome in SGLT2i initiators compar...
Figure S1. Flow diagram of study selection; Table S1. Primary and secondary endpoints, inclusion and...
Figure S3. Cox proportional hazards regression, unadjusted (A) and adjusted for age and gender (B) p...
Rates of reporting normative values for the Health Assessment Questionnaire-Disability Index (HAQ-DI...
Kaplan-Meier survival estimates according to the receipt of no diabetes medication, other diabetes m...
The selection process of study sample to determine optimal cut-points for prediction of type 2 diabe...
AHAs included in baseline regimen and with continued use in follow-up in patients with baseline and ...
Figure A2. Subgroup of OS2006 historical data (SARC-OS data). Observed Kaplan-Meier and parametric e...
Kaplan-Meier (KM) curves for all-cause death rates, macrovascular event rates and T2DM-related hospi...
Kaplan-Meier (KM) curves for crude all-cause death rates, macrovascular event rates and T2DM-related...
Distribution of propensity scores as calculated by logistic regression for MET/SU monotherapy users....
Kaplan-Meier (KM) curves for crude all-cause death rates, macrovascular event rates and T2DM-related...
Flow diagram of participants. Chart showing the number of participants who were randomly assigned, t...
Additional file 1: Table S1. Descriptive statistics for each drug and dose amount at index date in e...
A table showing adjusted hazard ratios based on the Cox proportional hazards model of 2-year mortali...
Additional file 5: Figure S3. Risk for cardiovascular and kidney outcome in SGLT2i initiators compar...
Figure S1. Flow diagram of study selection; Table S1. Primary and secondary endpoints, inclusion and...
Figure S3. Cox proportional hazards regression, unadjusted (A) and adjusted for age and gender (B) p...
Rates of reporting normative values for the Health Assessment Questionnaire-Disability Index (HAQ-DI...
Kaplan-Meier survival estimates according to the receipt of no diabetes medication, other diabetes m...
The selection process of study sample to determine optimal cut-points for prediction of type 2 diabe...
AHAs included in baseline regimen and with continued use in follow-up in patients with baseline and ...
Figure A2. Subgroup of OS2006 historical data (SARC-OS data). Observed Kaplan-Meier and parametric e...